| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |